Phenotypic Skewing of Macrophages In Vitro by Secreted Factors from Colorectal Cancer Cells

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Edin, Sofia ^a   Wikberg, Maria L ^a   Rutegård, Jörgen ^a   Oldenborg, Per Arne ^a   Palmqvist, Richard ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE;

ANTIGEN PRESENTATION; ARTICLE; CANCER CELL; CELL STRUCTURE; COLORECTAL CANCER; CONTROLLED STUDY; ENDOCYTOSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; MACROPHAGE MIGRATION; TUMOR ASSOCIATED LEUKOCYTE;

ANTIGEN PRESENTATION; CACO-2 CELLS; CELL MOVEMENT; CHEMOKINES; COCULTURE TECHNIQUES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MALE;

EID: 84884237300     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074982     Document Type: Article

References (30)

1. Allen M, Louise Jones J, (2011) Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol 223: 162-176.
2. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
3. Fridman WH, Pages F, Sautes-Fridman C, Galon J, (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12: 298-306.
4. Biswas SK, Mantovani A, (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11: 889-896.
5. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686.
6. Qian BZ, Pollard JW, (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141: 39-51.
7. Lanca T, Silva-Santos B, (2012) The split nature of tumor-infiltrating leukocytes: Implications for cancer surveillance and immunotherapy. Oncoimmunology 1: 717-725.
8. Mosser DM, Edwards JP, (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
9. Ruffell B, Affara NI, Coussens LM, (2012) Differential macrophage programming in the tumor microenvironment. Trends Immunol 33: 119-126.
10. Heusinkveld M, van der Burg SH, (2011) Identification and manipulation of tumor associated macrophages in human cancers. J Transl Med 9: 216.
11. Schmieder A, Michel J, Schonhaar K, Goerdt S, Schledzewski K, (2012) Differentiation and gene expression profile of tumor-associated macrophages. Semin Cancer Biol 22: 289-297.
12. Sica A, Schioppa T, Mantovani A, Allavena P, (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42: 717-727.
13. Algars A, Irjala H, Vaittinen S, Huhtinen H, Sundstrom J, et al. (2012) Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients. Int J Cancer 131: 864-873.
14. Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, et al. (2007) High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 13: 1472-1479.
15. Lackner C, Jukic Z, Tsybrovskyy O, Jatzko G, Wette V, et al. (2004) Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer. Virchows Arch 445: 160-167.
16. Nagorsen D, Voigt S, Berg E, Stein H, Thiel E, et al. (2007) Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival. J Transl Med 5: 62.
17. Zhou Q, Peng RQ, Wu XJ, Xia Q, Hou JH, et al. (2010) The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer. J Transl Med 8: 13.
18. Edin S, Wikberg ML, Dahlin AM, Rutegard J, Oberg A, et al. (2012) The distribution of macrophages with a m1 or m2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS One 7: e47045.
19. Soehnlein O, Lindbom L, (2010) Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 10: 427-439.
20. Siveen KS, Kuttan G, (2009) Role of macrophages in tumour progression. Immunol Lett 123: 97-102.
21. Klintrup K, Makinen JM, Kauppila S, Vare PO, Melkko J, et al. (2005) Inflammation and prognosis in colorectal cancer. Eur J Cancer 41: 2645-2654.
22. Nielsen HJ, Hansen U, Christensen IJ, Reimert CM, Brunner N, et al. (1999) Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol 189: 487-495.
23. Richards CH, Flegg KM, Roxburgh CS, Going JJ, Mohammed Z, et al. (2012) The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer. Br J Cancer 106: 2010-2015.
24. Porcheray F, Viaud S, Rimaniol AC, Leone C, Samah B, et al. (2005) Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 142: 481-489.
25. Stout RD, Jiang C, Matta B, Tietzel I, Watkins SK, et al. (2005) Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 175: 342-349.
26. Balkwill FR, (1992) Tumour necrosis factor and cancer. Prog Growth Factor Res 4: 121-137.
27. Trinchieri G, (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3: 133-146.
28. Balkwill FR, Mantovani A, (2012) Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol 22: 33-40.
29. Ong SM, Tan YC, Beretta O, Jiang D, Yeap WH, et al. (2012) Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response. Eur J Immunol 42: 89-100.
30. Weber B, Saurer L, Mueller C, (2009) Intestinal macrophages: differentiation and involvement in intestinal immunopathologies. Semin Immunopathol 31: 171-184.